Golo Overview
- Founded
-
2010

- Status
-
Private
- Employees
-
42

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.45M
- Investors
-
1
Golo General Information
Description
Operator of weight-loss management company intended to help individuals take control of their personal health. The company provides a healthy cost-effective way to lose weight permanently and helps with the problem of preventing weight loss insulin resistance, thereby helping people lose weight and get healthier and enjoy a sustainable lifestyle.
Contact Information
Website
www.golo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Other Healthcare Services
Information Services (B2C)
Primary Office
- 700 Prides Crossing
- Suite 304
- Newark, DE 19713
- United States
+1 (800) 000-0000
Golo Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 08-Feb-2016 | $2.45M | 00.000 | Completed | Generating Revenue | |
1. Angel (individual) | 24-Apr-2012 | 000 | 000 | Completed | Startup |
Golo Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of weight-loss management company intended to help individuals take control of their personal health. The compa
Other Consumer Non-Durables
Newark, DE
42
As of 2022
00.000
000000000
00.000
Golo Competitors (1)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
00000000000 | Private Equity-Backed | Fort Washington, PA | 000 | 000.00 | 000000000 | 000.00 |
Golo Patents
Golo Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210145915-A1 | Formulations for weight loss and methods of use | Active | 02-Feb-2017 | 000000000 | |
US-20220347252-A1 | Formulations for weight loss and methods of use | Pending | 02-Feb-2017 | 000000000 | |
US-11141448-B2 | Formulations for weight loss and methods of use | Active | 02-Feb-2017 | 000000000 | |
US-10765718-B2 | Formulations for weight loss and methods of use | Active | 02-Feb-2017 | 000000000 | |
US-11458182-B2 | Formulations for weight loss and methods of use | Active | 02-Feb-2017 | A61K36/73 | 00 |
Golo Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Chris Lundin | Chief Executive Officer & Board Member | ||
Jennifer Brooks | Co-Founder, President & Board Member | ||
Alexander Razzook | Chief Growth Officer |
Golo Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
Chris Lundin | Golo | Chief Executive Officer & Board Member | 000 0000 |
Jennifer Brooks | Golo | Co-Founder, President & Board Member | 000 0000 |
Peter Ungermann | Self | Board Member | 000 0000 |
Tony Hastie | Self | Board Member | 000 0000 |
Golo Signals
Golo Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Tony Hastie | Angel (individual) | Minority | 000 0000 | 000000 0 |